Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Culture

Beneath Joy Of ‘Beauty And The Beast,’ A Songwriting Duo’s Grief

Disney’s 1991 animated hit “Beauty and the Beast” opens on a note of frustrated promise, as the protagonist, Belle, wends her way through her small French town. Curious and bookish, Belle feels she can’t realize her dreams while grappling with the constraints of country life.

The story of of the film’s famous songs — “Be Our Guest,” “Beauty and the Beast,” “Gaston,” and more — is also one of frustrated promise.

Composer Alan Menken. Image by Jamie McCarthy/Getty Images

In a new interview with The Guardian’s Ben Beaumont-Thomas and Phil Hoad, composer Alan Menken discussed the tragedy that, for him, underlined the process of working on the film: While it was in development and production his songwriting partner, lyricist Howard Ashman, was in the final stages of his struggle with AIDS.

“I eventually found out about his illness just after we won the Oscars for The Little Mermaid,” Menken said. “No one else was to know – it was a death sentence, and people wouldn’t want to be in the room with him.”

Ashman, he said, was in his early 30s at the time. “Beauty and the Beast” would be the last project he ever worked on.

At some point in the film’s production, Menken remembered, Ashman’s illness became too pronounced to conceal from Disney. The producers responded by moving as much of the film’s musical production as possible to be accessible to him from his home on the east coast.

“He made it through all the last recording sessions,” Menken said. “For ‘Something There,’ Paige O’Hara was singing the line: ‘New, and a bit alarming.’ By now Howard was nearly blind and could barely talk. But he said in this hoarse whisper, over the phone from his bed: ‘Tell Paige, when she gets to ‘alarming’: Streisand!’”

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.